DC3 Therapeutics
UEI: EHDBBFU1ER95
• CAGE: 994D2
Overview
Awardee Type
Parent
Name
DC3 Therapeutics
Website
Headquarters
South San Francisco, CA
United States
United States
Most Recent Award
Aug. 1, 2025
Calculating
Federal contract recipient
DC3 THERAPEUTICS, LLC
(UEI EHDBBFU1ER95, CAGE 994D2)
is headquartered in South San Francisco CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in August 2013 and
federally registered in
February 2022.
Federal Award Analysis
DC3 Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
DC3 THERAPEUTICS, LLC
UEI
EHDBBFU1ER95
CAGE Code
994D2
SBA Certifications
None
Self Certifications
Black American Owned
Minority Owned Business
Self-Certified Small Disadvantaged Business
Minority Owned Business
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 13, 2013
Initial Registration
Feb. 4, 2022
Last Registration
July 14, 2025
Registration Activation
July 14, 2025
Registration Expiration
July 10, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
CA
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No